Today on DrugResearcher.com   GSK hopes boron drugs can tackle pathogen resistance Rumours of Pfizer, Sanofi mega-merger emerge Proteomics shows 3D cell cultures are better than 2D A 'virtual immune system' for drug developers US firm unveils new cell culture services

Related Industry News   Univar fills EU phosphate gap FDA backs tablet imaging tech Bavarian Nordic meets milestones 'We are not anti-Asia' says EU chemicals body

Breaking News on Drug Discovery
Daily  Tuesday 09 October 2007		Forward to a colleague

	Company Profile ClonePix FL - explore cell surfaces discover stellar clones ClonePix FL technology makes light-work of selecting and isolating mammalian cell clones by cell surface protein expression, rapidly yielding monoclonal populations for cell based assays, screening, downstream phenotyping/genotyping and basic discovery research... Click Here Access Full Stories GSK hopes boron drugs can tackle pathogen resistance GlaxoSmithKline (GSK) thinks that drugs based on boron, rather than carbon, could side-step the issue of resistance in anti-bacterial and anti-viral therapy - and is willing to bet billions on it... Read Rumours of Pfizer, Sanofi mega-merger emerge Rumours that Pfizer is looking into buying a large stake in Sanofi-Aventis, which could be seen as a prelude to a full takeover bid, has prompted a flurry of shareholder activity... Read Proteomics shows 3D cell cultures are better than 2D German researchers have shown 3D cell structures better resemble tumour phenotypes than traditional cultures, suggesting they will make better models for testing new anticancer agents... Read A 'virtual immune system' for drug developers A group of scientists are using real-world experimental data to generate a virtual model of the human immune system, which could then be used in drug design... Read US firm unveils new cell culture services US drug discovery firm BioProcessors has unveiled a new range of cell culture services to assist in biopharmaceutical process development... Read
	All News Headlines for: October | September | August
	Technical / White Paper Manufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here
	Related Industry News Univar fills EU phosphate gap Dutch chemicals and excipients distributor Univar has hooked up with US manufacturer Innophos to provide the EU pharmaceutical market with its entire portfolio of excipients, helping to fill the gap left by the... Read FDA backs tablet imaging tech UK-based TeraView has had its tablet imaging technology backed by the US Food and Drug Administration (FDA), following a study by the regulatory agency... Read Bavarian Nordic meets milestones Denmark-based Bavarian Nordic has received an advance payment of $50m (€35.4m) from the US Government for meeting milestones in one of its smallpox vaccine supply contracts... Read 'We are not anti-Asia' says EU chemicals body There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India.  However,... Read Weekly Comment FDA told its safety monitoring of clinical trials not good enough The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials. Read Previous Headlines Fathers of 'targeted genetics' scoop Nobel prize The discoverer of embryonic stem cells (ES cells) and two other scientists have won a Nobel Prize for their work to develop a 'magic wand' to modify the mouse genome... Read Pharmaceuticals is top R&D spender As an increasingly desperate pharma industry strives to fill drug pipelines, the sector has, for the first time, topped a poll of which industries spend the most on research and development... Read UK innovation to get billion pound boost The UK government has set-aside £1bn (€1.45bn) to give early-stage companies better support after a review of the UK's science and innovation policies by Lord Sainsbury of Turville... Read Novartis osteoporosis drug gets EU nod Swiss pharma Novartis has got the thumbs up from the EU for its once-yearly treatment for postmenopausal osteoporosis... Read Clinical staffing a 'tremendous problem' The European clinical trials industry is experiencing a "tremendous problem" with staff recruitment - salaries are climbing as a result... Read Technical / White Papers, Case studies, Web casts Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com